Abstract: Cutaneous metastasis is the main cause of morbidity and mortality of cancer patients, denoting a guarded prognosis. The clinical spectrum of the disease is broad and can mimic benign conditions. The diagnosis depends on thorough clinical examination and complementary exams, with emphasis on the histopathological study and immunohistochemistry. Because it indicates a systemic relapse, it is necessary to intervene with intravenous chemotherapy, to which local therapies can be associated. We report the case of a 65-year-old woman with cutaneous metastasis from breast cancer treated 14 years back, manifested by extensive firm and infiltrated red-purple plaques on the sides of the trunk, with a course of six months. After evaluation, she was referred to the regional cancer center. She passed away one month and a half later.
INTRODUCTION
Cutaneous metastasis is rare and represents a sign of malignancy and poor prognosis. It occurs in 0.7% to 10.4% of all cancers and represents 2% of cutaneous tumors. 1 Breast cancer is the second most common cancer in women, with metastasis rates of up to 23.9%, and is the first in causing cutaneous metastasis. 1, 2 It occurs more commonly between 50 to 70 years of age, usually in the first three years after diagnosis of the cancer. 1 We described the case of a patient with florid lesions of cutaneous metastasis of breast cancer.
CASE REPORT
A 65-year-old woman had been developing plaques on her trunk over the past 6 months, lymph node enlargement on the left inguinal region (a painless, firm nodule) and loss of 15 kg during that time. She reported a previous history of breast cancer on the left breast 14 years prior, that was treated with radical mastectomy, and adjuvant chemotherapy (CT) and radiotherapy (RT). On dermatological examination, she had extensive erythematous-purplish firm plaques on both sides of the trunk (Figures 1 and 2 ). 
DISCUSSION
Cutaneous metastasis can be the first indication of recurrence of a cancer that was supposedly treated or it can represent the primary manifestation of an unknown internal malignancy. • Telangiectatic carcinoma: erythematous papules with telangiectasia.
• Carcinoma en cuirasse: darkened lesion, translucent skin, with an "orange peel" aspect, resembling morphea.
• Neoplastic alopecia: cicatricial alopecia, anywhere on the scalp.
• Zosteriform metastasis: cutaneous nodules along a dermatome.
• Other possible presentations: sclerodermiform, inflammatory carcinoma and palpebral nodules. and TTF-1.
1
The differential diagnoses are cysts, lipomas, adnexal tumors, dermatofibromas, keratoacanthomas, keloids, lymphocytomas, hansenomas, benign and malignant vascular lesions, morphea, erysipelas, radiation dermatitis, cicatricial alopecia, among others. 3, 4 Treatments are based on CT, RT, immunotherapy, surgical excision, heat and, many times, watchful waiting and palliation. Metastatic cutaneous metastasis are manifestations of systemic recurrence; therefore, the therapy should never be only topical, requiring associated systemic CT even when only the skin is affected. 2 The cutaneous response to the treatment can be used as a parameter in the evaluation of the systemic treatment. 4 In general, the prognosis for cutaneous metastasis of breast cancer is poor, with a short survival.
According to the literature, the patient had the most frequent age group and site of lesions but, had extensive plaques on the chest instead of nodules, with the clinical aspect of carcinoma en cuirasse.
Despite having received the recommended treatment, the poor prognosis was confirmed with the quick progression to death.q
